Diagnostics (Feb 2024)

Optical Emission Spectroscopy for the Real-Time Identification of Malignant Breast Tissue

  • Selin Guergan,
  • Bettina Boeer,
  • Regina Fugunt,
  • Gisela Helms,
  • Carmen Roehm,
  • Anna Solomianik,
  • Alexander Neugebauer,
  • Daniela Nuessle,
  • Mirjam Schuermann,
  • Kristin Brunecker,
  • Ovidiu Jurjut,
  • Karen A. Boehme,
  • Sascha Dammeier,
  • Markus D. Enderle,
  • Sabrina Bettio,
  • Irene Gonzalez-Menendez,
  • Annette Staebler,
  • Sara Y. Brucker,
  • Bernhard Kraemer,
  • Diethelm Wallwiener,
  • Falko Fend,
  • Markus Hahn

DOI
https://doi.org/10.3390/diagnostics14030338
Journal volume & issue
Vol. 14, no. 3
p. 338

Abstract

Read online

Breast conserving resection with free margins is the gold standard treatment for early breast cancer recommended by guidelines worldwide. Therefore, reliable discrimination between normal and malignant tissue at the resection margins is essential. In this study, normal and abnormal tissue samples from breast cancer patients were characterized ex vivo by optical emission spectroscopy (OES) based on ionized atoms and molecules generated during electrosurgical treatment. The aim of the study was to determine spectroscopic features which are typical for healthy and neoplastic breast tissue allowing for future real-time tissue differentiation and margin assessment during breast cancer surgery. A total of 972 spectra generated by electrosurgical sparking on normal and abnormal tissue were used for support vector classifier (SVC) training. Specific spectroscopic features were selected for the classification of tissues in the included breast cancer patients. The average classification accuracy for all patients was 96.9%. Normal and abnormal breast tissue could be differentiated with a mean sensitivity of 94.8%, a specificity of 99.0%, a positive predictive value (PPV) of 99.1% and a negative predictive value (NPV) of 96.1%. For 66.6% patients all classifications reached 100%. Based on this convincing data, a future clinical application of OES-based tissue differentiation in breast cancer surgery seems to be feasible.

Keywords